@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP431981.RAZllkUO2zT2oHGOjKi1p09_GAoKrJH_92OLRYkaqjmdg130_head { this: np:hasAssertion dgn-np:NP431981.RAZllkUO2zT2oHGOjKi1p09_GAoKrJH_92OLRYkaqjmdg130_assertion; np:hasProvenance dgn-np:NP431981.RAZllkUO2zT2oHGOjKi1p09_GAoKrJH_92OLRYkaqjmdg130_provenance; np:hasPublicationInfo dgn-np:NP431981.RAZllkUO2zT2oHGOjKi1p09_GAoKrJH_92OLRYkaqjmdg130_publicationInfo; a np:Nanopublication . dgn-np:NP431981.RAZllkUO2zT2oHGOjKi1p09_GAoKrJH_92OLRYkaqjmdg130_assertion a np:Assertion . dgn-np:NP431981.RAZllkUO2zT2oHGOjKi1p09_GAoKrJH_92OLRYkaqjmdg130_provenance a np:Provenance . dgn-np:NP431981.RAZllkUO2zT2oHGOjKi1p09_GAoKrJH_92OLRYkaqjmdg130_publicationInfo a np:PublicationInfo . } dgn-np:NP431981.RAZllkUO2zT2oHGOjKi1p09_GAoKrJH_92OLRYkaqjmdg130_assertion { miriam-gene:55349 a ncit:C16612 . lld:C0013274 a ncit:C7057 . dgn-gda:DGN903f11e2e10c9bcf7e8e766414bad872 sio:SIO_000628 miriam-gene:55349, lld:C0013274; a sio:SIO_001121 . } dgn-np:NP431981.RAZllkUO2zT2oHGOjKi1p09_GAoKrJH_92OLRYkaqjmdg130_provenance { dgn-np:NP431981.RAZllkUO2zT2oHGOjKi1p09_GAoKrJH_92OLRYkaqjmdg130_assertion dcterms:description "[The relative risk of any dissimilar CHD given the specified CHD in first-degree relatives was as follows: heterotaxia, 2.00 (95% CI, 0.96 to 4.17); conotruncal defects, 2.78 (95% CI, 2.12 to 3.66); atrioventricular septal defects, 2.25 (95% CI, 1.39 to 3.66); anomalous pulmonary venous return, 1.76 (95% CI, 0.66 to 4.64); left- and right-ventricular outflow tract obstruction, 2.55 (95% CI, 1.87 to 3.48) and 3.09 (95% CI, 2.03 to 4.71), respectively; isolated atrial septal defects, 2.76 (95% CI, 2.11 to 3.61); isolated ventricular septal defects, 2.27 (95% CI, 1.75 to 2.94); persistent ductus arteriosus, 1.92 (95% CI, 1.32 to 2.79); other specified CHDs, 3.29 (95% CI, 2.51 to 4.32); and unspecified CHDs, 2.30 (95% CI, 1.76 to 3.00).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:20173214; prov:wasDerivedFrom dgn-void:befree-20140225; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-20140225 pav:importedOn "2014-02-25"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP431981.RAZllkUO2zT2oHGOjKi1p09_GAoKrJH_92OLRYkaqjmdg130_publicationInfo { this: dcterms:created "2014-10-02T12:36:16+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetrdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v2.1.0.0" . dgn-void:disgenetrdf pav:version "v2.1.0" . }